Using lymph node fine needle aspirates for gene expression profiling of canine lymphoma

Veterinary and Comparative Oncology

Volumn 8, Issue 1, 2010, Pages 56-71

  Starkey, M P ^a   Murphy, S ^a  

^a ANIMAL HEALTH TRUST   (United Kingdom)

Author keywords

Canine; Fine needle aspirate; Gene expression profiling; Lymphoma

Indexed keywords

TUMOR MARKER; TUMOR PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LYMPH NODE; LYMPHOMA; METABOLISM; NEEDLE BIOPSY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BIOPSY, FINE-NEEDLE; DOG DISEASES; DOGS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; LYMPH NODES; LYMPHOMA; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 75249105977     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2009.00205.x     Document Type: Article

References (68)

1. Dorn CR, Taylor DO, Hibbard HH. Epizootiologic characteristics of canine and feline leukemia and lymphoma. American Journal of Veterinary Research 1967, 28:993-1001.
2. Edwards DS, Henley WE, Harding EF, Dobson JM, Wood JLN. Breed incidence of lymphoma in a UK population of insured dogs. Veterinary and Comparative Oncology 2003, 4:200-206.
3. MacEwen EG. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Metastasis Reviews 1990, 9:125-136.
4. Teske E, van Heerde P, Rutteman GR, Kurzman ID, Moore PF, MacEwen EG. Prognostic factors for treatment of malignant lymphoma in dogs. Journal of the American Veterinary Medicine Association 1994, 205:1722-1728.
5. Jagielski D, Lechowski R, Hoffmann-Jagielska M, Winiarczyk S. A retrospective study of the incidence and prognostic factors of multicentric lymphoma in dogs (1998-2000). Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine 2002, 49:419-424.
6. Greenlee PG, Filippa DA, Quimby FW, Patnaik AK, Calvano SE, Matus RE, Kimmel M, Hurvitz AI, Lieberman PH. Lymphomas in dogs. A morphologic, immunologic, and clinical study. Cancer 1990, 66:480-490.
7. Kiupel M, Teske E, Bostock D. Prognostic factors for treated canine malignant lymphoma. Veterinary Pathology 1999, 36:292-300.
8. Dobson JM, Blackwood LB, McInnes EF, Bostock DE, Nicholls P, Hoather TM, Tom BD. Prognostic variables in canine multicentric lymphosarcoma. The Journal of Small Animal Practice 2001, 42:377-384.
9. Ponce F, Magnol JP, Ledieu D, Marchal T, Turinelli V, Chalvet-Monfray K, Fournel-Fleury C. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy. Veterinary Journal 2004, 167:158-166.
10. Hahn KA, Richardson RC, Hahn EA, Chrisman CL. Diagnostic and prognostic importance of chromosomal aberrations identified in 61 dogs with lymphosarcoma. Veterinary Pathology 1994, 31:528-540.
11. Thomas R, Smith KC, Ostrander EA, Galibert F, Breen M. Chromosome aberrations in canine multicentric lymphomas detected with comparative genomic hybridisation and a panel of single locus probes. British Journal of Cancer 2003, 89:1530-1537.
12. Winkler S, Murua Escobar H, Reimann-Berg N, Bullerdiek J, Nolte I. Cytogenetic investigations in four canine lymphomas. Anticancer Research 2005, 25:3995-3998.
13. Savage KJ, Gascoyne RD. Molecular signatures of lymphoma. International Journal of Hematology 2004, 80:401-409.
14. Staudt LM, Dave S. The biology of human lymphoid malignancies revealed by gene expression profiling. Advances in Immunology 2005, 87:163-208.
15. Dave S. Gene expression profiling and outcome prediction in non-Hodgkin lymphoma. Biology of Blood and Marrow Transplantation 2006, 12:50-52.
16. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
17. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, Lopez-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T, Staudt LM. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. New England Journal of Medicine 2002, 346:1937-1947.
18. Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, Ray TS, Koval MA, Last KW, Norton A, Lister TA, Mesirov J, Neuberg DS, Lander ES, Aster JC, Golub TR. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nature Medicine 2002, 8:68-74.
19. Shin J, Monti S, Aires DJ, Duvic M, Golub T, Jones DA, Kupper TS. Lesional gene expression profiling in cutaneous T cell lymphoma reveals natural clusters associated with disease outcome. Blood 2007, 110:3015-3027.
20. Fournel-Fleury C, Ponce F, Felman P, Blavier A, Bonnefont C, Chabanne L, Marchal T, Cadore JL, Goy-Thollot I, Ledieu D, Ghernati I, Magnol JP. Canine T-cell lymphomas: a morphological, immunological, and clinical study of 46 new cases. Veterinary Pathology 2002, 39:92-100.
21. 2009, http://www.ensembl.org/Multi/blastview, Ensembl Genome Browser 54:, -BlastView (, [accessed 26 March 2009].
22. Dunmire V, Wu C, Symmans WF, Zhang W. Increased yield of total RNA from fine-needle aspirates for use in expression microarray analysis. Biotechniques 2002, 33:890-896.
23. Chenchik A, Zhu YY, Diatchenko L, Li R, Hill J, Siebert PD, Siebert PD, Larrick JW. Gene Cloning and Analysis by RT-PCR 1998, 305-319. In:, eds.,, Natick, BioTechniques Books
24. Van Gelder RN, von Zastrow ME, Yool A, Dement WC, Barchas JD, Eberwine JH. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:1663-1667.
25. Petalidis L, Bhattacharyya S, Morris GA, Collins VP, Freeman TC, Lyons PA. Global amplification of mRNA by template-switching PCR: linearity and application to microarray analysis. Nucleic Acids Research 2003, 31:1-7.
26. Quackenbush J. Microarray data normalization and transformation. Nature Genetics 2002, 32:496-501. (Suppl.):
27. Camargo A, Azuaje F, Wang H, Zheng H. Permutation-based statistical tests for multiple hypotheses. Source Code for Biology and Medicine 2008, 3:15-22.
28. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:14863-14868.
29. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nature Genetics 2001, 29:365-371.
30. Mueller O, Lightfoot S, Schroeder A. RNA Integrity Number (RIN)-standardization of RNA quality control. 2004, 1-8. Publication Number-5989-1165EN:
31. Imbeaud S, Graudens E, Boulanger V, Barlet X, Zaborski P, Eveno E, Mueller O, Schroeder A, Auffray C. Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Research 2005, 33:e56-67.
32. Lukin K, Fields S, Hartley J, Hagman J. Early B cell factor: regulator of B lineage specification and commitment. Seminars in Immunology 2008, 20:221-227.
33. Jimenez MA, Akerblad P, Sigvardsson M, Rosen ED. Critical role for Ebf1 and Ebf2 in the adipogenic transcriptional cascade. Molecular and Cellular Biology 2007, 27:743-757.
34. Isogai Z, Ono RN, Ushiro S, Keene DR, Chen Y, Mazzieri R, Charbonneau NL, Reinhardt DP, Rifkin DB, Sakai LY. Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. Journal of Biological Chemistry 2003, 278:2750-2757.
35. Ghosh AK, Varga J. The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis. Journal of Cellular Physiology 2007, 213:663-671.
36. Paulsen M, Ussat S, Jakob M, Scherer G, Lepenies I, Schütze S, Kabelitz D, Adam-Klages S. Interaction with XIAP prevents full caspase-3/-7 activation in proliferating human T lymphocytes. European Journal of Immunology 2008, 38:1979-1987.
37. Zauli G, Previati M, Caramelli E, Bassini A, Falcieri E, Gibellini D, Bertolaso L, Bosco D, Robuffo I, Capitani S. Exogenous human immunodeficiency virus type-1 Tat protein selectively stimulates a phosphatidylinositol-specific phospholipase C nuclear pathway in the Jurkat T cell line. European Journal of Immunology 1995, 25:2695-2700.
38. Massarelli G, Onida GA, Piras MA, Marras V, Mura A, Tanda F. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas. Anticancer Research 1999, 19:3933-3938.
39. Pechumer H, Bender-Götze C, Ziegler-Heitbrock HW. Detection of neuron-specific gamma-enolase messenger ribonucleic acid in normal human leukocytes by polymerase chain reaction amplification with nested primers. Laboratory Investigations 1993, 69:743-749.
40. Centeno BA, Enkemann SA, Coppola D, Huntsman S, Bloom G, Yeatman TJ. Classification of human tumors using gene expression profiles obtained after microarray analysis of fine-needle aspiration biopsy samples. Cancer 2005, 105:101-109.
41. Morrison C, Palatini J, Riggenbach J, Radmacher M, Porcu P. Fine-needle aspiration biopsy of non-Hodgkin lymphoma for use in expression microarray analysis. Cancer 2006, 108:311-318.
42. Bakay M, Chen YW, Borup R, Zhao P, Nagaraju K, Hoffman EP. Sources of variability and effect of experimental approach on expression profiling data interpretation. BMC Bioinformatics 2002, 3:4-15.
43. Von Euler H, Khoshnoud R, He Q, Khoshnoud A, Fornander T, Rutqvist LE, Skog S. Time-dependent RNA degradation affecting cDNA array quality in spontaneous canine tumours sampled using standard surgical procedures. International Journal of Molecular Medicine 2005, 16:979-985.
44. Makrigiorgos GM, Chakrabarti S, Zhang Y, Kaur M, Price BD. A PCR-based amplification method retaining the quantitative difference between two complex genomes. Nature Biotechnology 2002, 20:936-939.
45. Wang E, Miller LD, Ohnmacht GA, Liu ET, Marincola FM. High-fidelity mRNA amplification for gene profiling. Nature Biotechnology 2000, 18:457-459.
46. Li Y, Ali S, Philip PA, Sarkar FH. Direct comparison of microarray gene expression profiles between non-amplification and a modified cDNA amplification procedure applicable for needle biopsy tissues. Cancer Detection and Prevention 2003, 27:405-411.
47. Che S, Ginsberg SD. Amplification of RNA transcripts using terminal continuation. Laboratory Investigations 2004, 84:131-137.
48. Iscove NN, Barbara M, Gu M, Gibson M, Modi C, Winegarden N. Representation is faithfully preserved in global cDNA amplified exponentially from sub-picogram quantities of mRNA. Nature Biotechnology 2002, 20:940-943.
49. Seth D, Gorrell MD, McGuinness PH, Leo MA, Lieber CS, McCaughan GW, Haber PS. SMART amplification maintains representation of relative gene expression: quantitative validation by real time PCR and application to studies of alcoholic liver disease in primates. Journal of Biochemical and Biophysical Methods 2003, 55:53-66.
50. Puskás LG, Zvara A, Hackler L, Van Hummelen P. RNA amplification results in reproducible microarray data with slight ratio bias. Biotechniques 2002, 32:1330-1340.
51. Crnogorac-Jurcevic T, Efthimiou E, Capelli P, Blaveri E, Baron A, Terris B, Jones M, Tyson K, Bassi C, Scarpa A, Lemoine NR. Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene 2001, 20:7437-7446.
52. Ernst LM, Rimm DL. Quantitative examination of mechanophysical tumor cell enrichment in fine-needle aspiration specimens. Cancer 2002, 96:275-279.
53. Symmans WF, Ayers M, Clark EA, Stec J, Hess KR, Sneige N, Buchholz TA, Krishnamurthy S, Ibrahim NK, Buzdar AU, Theriault RL, Rosales MF, Thomas ES, Gwyn KM, Green MC, Syed AR, Hortobagyi GN, Pusztai L. Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma. Cancer 2003, 97:2960-2971.
54. Glanzer JG, Eberwine JH. Expression profiling of small cellular samples in cancer: less is more. British Journal of Cancer 2004, 90:1111-1114.
55. King C, Guo N, Frampton GM, Gerry NP, Lenburg ME, Rosenberg CL. Reliability and reproducibility of gene expression measurements using amplified RNA from laser-microdissected primary breast tissue with oligonucleotide arrays. Journal of Molecular Diagnostics 2005, 7:57-64.
56. Li H, Fan X, Houghton J. Tumor microenvironment: the role of the tumor stroma in cancer. Journal of Cellular Biochemistry 2007, 101:805-815.
57. Latil A, Bieche I, Chene L, Laurendeau I, Berthon P, Cussenot O, Vidaud M. Gene expression profiling in clinically localized prostate cancer: a four-gene expression model predicts clinical behavior. Clinical Cancer Research 2003, 9:5477-5485.
58. Bieche I, Tozlu S, Girault I, Lidereau R. Identification of a three-gene expression signature of poor-prognosis breast carcinoma. Molecular Cancer 2004, 3:37-46.
59. Zehentner BK, Persing DH, Deme A, Toure P, Hawes SE, Brooks L, Feng Q, Hayes DC, Critichlow CW, Houghton RL, Kiviat NB. Mammaglobin as a novel breast cancer biomarker: multigene reverse transcription-PCR assay and sandwich ELISA. Clinical Chemistry 2004, 50:2069-2076.
60. Weber F, Shen L, Aldred MA, Morrison CD, Frilling A, Saji M, Schuppert F, Broelsch CE, Ringel MD, Eng C. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination. The Journal of Clinical Endocrinology and Metabolism 2005, 90:2512-2521.
61. Lossos IS, Jones CD, Warnke R, Natkunam Y, Kaizer H, Zehnder JL, Tibshirani R, Levy R. Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood 2001, 98:945-951.
62. Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, Botstein D, Levy R. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. New England Journal of Medicine 2004, 350:1828-1837.
63. Sakhinia E, Glennie C, Hoyland JA, Menasce LP, Brady G, Miller C, Radford JA, Byers RJ. Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling. Blood 2007, 109:3922-3928.
64. Bueno R, Loughlin KR, Powell MH, Gordon GJ. A diagnostic test for prostate cancer from gene expression profiling data. Journal of Urology 2004, 171:903-906.
65. Mazzanti C, Zeiger MA, Costouros NG, Umbricht C, Westra WH, Smith D, Somervell H, Bevilacqua G, Alexander HR, Libutti SK. Using gene expression profiling to differentiate benign versus malignant thyroid tumors. Cancer Research 2004, 64:2898-2903.
66. Sotiriou C, Powles TJ, Dowsett M, Jazaeri AA, Feldman AL, Assersohn L, Gadisetti C, Libutti SK, Liu ET. Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer. Breast Cancer Research 2002, 4:R3-10.
67. Goy A, Stewart J, Barkoh BA, Remache YK, Katz R, Sneige N, Gilles F. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma. Cancer 2006, 108:10-20.
68. Catchpole B, Gould SM, Kellett-Gregory LM, Dobson JM. Development of a multiple-marker polymerase chain reaction assay for detection of metastatic melanoma in lymph node aspirates of dogs. American Journal of Veterinary Research 2003, 64:544-549.